The effects of co-therapy with recombinant human insulin-like growth factor I and insulin on serum leptin levels in adolescents with type 1 diabetes mellitus

Pediatric Diabetes

Volumn 2, Issue 1, 2001, Pages 25-29

  Thrailkill, Kathryn M ^a,d   Fowlkes, John L ^a   Hyde, James F ^b   Litton, Jean C ^c  

^a Department of Pediatrics ^*  (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Adipose tissue; Insulin like growth factor binding proteins; Insulin like growth factors; Obesity

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ISOPHANE INSULIN; LEPTIN; RECOMBINANT SOMATOMEDIN C;

ADOLESCENCE; ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENDER; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LONG TERM CARE; MALE; METABOLIC REGULATION; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0035027752     PISSN: 1399543X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-543x.2001.020105.x     Document Type: Article

References (27)

1. Molecular physiology of leptin and its receptor
2. Expression of ob gene in adipose cells
3. Regulated expression of the obese product (leptin) in white adipose tissue and 3T3-L1 adipocytes
4. Regulation of leptin production in cultured mature white adipocytes
5. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: Reversal by insulin
6. Plasma leptin in diabetic and insulin-treated diabetic and normal rats
7. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM
8. Leptin before and after insulin therapy in children with new-onset type I diabetes
9. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats
10. Acute leptin regulation in end-stage renal failure: The role of growth hormone and IGF-I
11. Dual hormonal replacement with insulin and recombinant human insulin-like growth factor I in insulin dependent diabetes mellitus: Effects on glycemic control, IGF-I levels and safety profile
12. For the rhIGF-I in IDDM Study Group. Cotherapy with recombinant human insulin-like growth factor-I and insulin improves glycemic control in Type 1 Diabetes
13. The effects of recombinant insulin-like growth factor-I and growth hormone on body composition in elderly women
14. Radioimmunoassay of leptin in human plasma
15. Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: Effects on the growth hormone/IGF/IGF-binding protein system
16. Serum leptin levels in normal children: Relationship to age, gender, body mass index, pituitary-gonadal hormones and pubertal stage
17. Serum leptin levels in children and adolescents with insulin-dependent diabetes mellitus in relation to metabolic control and body mass index
18. High serum leptin levels in children with type 1 diabetes mellitus: Contribution of age, BMI, pubertal development and metabolic status
19. Intraperitoneal insulin reduces plasma leptin concentrations in diabetic patients on CAPD
20. Association of endogenous insulin secretion and mode of therapy with body fat and serum leptin levels in diabetic subjects
21. Acute and chronic effects of insulin on leptin production in humans
22. Recombinant human insulin-like growth factor-I (IGF-I) therapy decreases plasma leptin concentration in patients with chronic renal insufficiency
23. Leptin binding activity (LBA) in plasma of nondiabetic and diabetic adolescents and obese children: Relation to auxologic and hormonal data
24. Human plasma leptin in obese subjects and diabetics
25. Insulin regulation of leptin expression in streptozotocin diabetic pigs
26. Changes in free insulin-like growth factor-1 and leptin concentrations during acute metabolic decompensation in insulin withdrawn patients with type 1 diabetes
27. Insulin increases serum leptin concentrations in children and adolescents with newly diagnosed type I diabetes mellitus with and without ketoacidosis